BOSTON--(BUSINESS WIRE)--Mar. 1, 2016--
Pharma, Inc. (NASDAQ: FLKS), a biotechnology company developing
innovative and proprietary treatments for nocturnal leg cramps (NLC),
spasms associated with severe neuromuscular
conditions, and exercise-associated muscle cramps, announced today that
it will report its financial results for the year ended December 31,
2015 on Tuesday, March 8, 2016 before the U.S. financial markets open.
The Company will host a conference call and webcast at 8:30 a.m. ET to
discuss 2015 financial results and provide a business update.
Individuals interested in participating in the call should dial (855)
780-7202 (U.S. and Canada) or (631) 485-4874 (International).
A live webcast may be accessed in the Investors section of the Company's
website at www.flex-pharma.com.
Please log on to the Flex Pharma website approximately 15 minutes prior
to the scheduled webcast to ensure adequate time for any software
downloads that may be required. A replay of the webcast will be
available on Flex Pharma's website for three months.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for nocturnal leg cramps, spasms
associated with severe neuromuscular conditions such as ALS and
MS, and exercise-associated muscle cramps. Flex Pharma was founded by
National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel
Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of
ion channels and neurobiology, along with Chair and CEO Christoph
Westphal, M.D., Ph.D.
Follow Flex Pharma on twitter (@flexpharma) and visit the Company’s
web site (http://ir.flex-pharma.com/) for
updates of the Company's pre-launch activities for its
consumer product to prevent and treat exercise-associated muscle cramps.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160301005453/en/
Source: Flex Pharma, Inc.
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
Relations & Corporate Communications